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Abstract Autopsy-negative sudden cardiac deaths (SCD)
seen in forensic practice are most often thought to be the
result of sudden arrhythmic death syndrome. Postmortem
genetic analysis is recommended in such cases, but is
currently performed in only a few academic centers. In
order to determine actual current practice, an on-line
questionnaire was sent by e-mail to members of various
forensic medical associations. The questions addressed
routine procedures employed in cases of sudden cardiac
death (autopsy ordering, macroscopic and microscopic
cardiac examination, conduction tissue examination, immu-
nohistochemistry and electron microscopy, biochemical
markers, sampling and storage of material for genetic
analyses, toxicological analyses, and molecular autopsy).
Some questions concerned the legal and ethical aspects of
genetic analyses in postmortem examinations, as well as
any existing multidisciplinary collaborations in SCD cases.
There were 97 respondents, mostly from European
countries. Genetic testing in cases of sudden cardiac death
is rarely practiced in routine forensic investigation. Ap-
proximately 60% of respondents reported not having the
means to perform genetic postmortem testing and 40% do
not collect adequate material to perform these investiga-
tions at a later date, despite working at university hospitals.
The survey demonstrated that many of the problems
involved in the adequate investigation of SCD cases are
often financial in origin, due to the fact that activities in
forensic medicine are often paid by and dependent on the
judicial authorities. Problems also exist concerning the
contact with family members and/or the family doctor, as
well as the often-nonexistent collaboration with others
clinicians with special expertise beneficial in the investiga-
tion of SCD cases, such as cardiologists and geneticists.
This study highlights the importance in establishing guide-
lines for molecular autopsies in forensic medicine.
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Introduction
The recommendations for the forensic investigation of
sudden cardiac deaths (SCD) are numerous, addressing
both the autopsy and complementary analyses [1, 2]. In
cases of autopsy-negative sudden deaths, often attributed to
sudden arrhythmic death syndrome, postmortem genetic
testing (a.k.a molecular autopsy) is recommended [3–5].
Recent progress in the fields of molecular biology and
human genetics has identified the genetic origin of many
cardiac diseases [6–10], resulting in SCD and found in
Sudden Infant Death Syndrome (SIDS) [4–6, 8, 10–12].
SCD may be prevented if the appropriate treatment is
initiated in affected individuals. As many of these diseases
are hereditary, establishing a postmortem diagnosis of a
SCD victim is very important for the surviving family
members. In 2007, Wedekind stated that postmortem
genetic testing should be considered as a part of the
comprehensive medicolegal investigation in sudden cardiac
death cases without apparent structural heart disease, taking
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into consideration the implications for the living family
members [13]. Establishing a diagnosis may prevent future
cardiac events with the assistance of expert counseling,
appropriate lifestyle adjustment, and pharmacological treat-
ment, if available. Recently, Dettmyer and Kandolf sug-
gested that some cases of primary arrythmogenic disorders
were misdiagnosed as SIDS [14], and Klintschar reported
on the clinical consequences for family members resulting
from a medicolegal autopsy in a case of sudden death due
to an aortic rupture resulting from Marfan syndrome [15].
Despite the recommendations for and advantages of
molecular autopsy, only a few research centers are currently
performing it in standard forensic practice. The goal of this
project was to assess the current strategies employed by
forensic practitioners.
Methods
The members of forensic medical associations (Internation-
al Academy of Legal Medicine, German, Swiss and, French
Societies of Legal Medicine and Mediterranean Academy
of Forensic Sciences) were contacted by email and asked to
fill out an on-line questionnaire, which was available during
a 2-week period. A total of 648 mails were sent; however,
the mailing list was not selective and included members not
involved in the autopsy of SCD cases, such as toxicologists
and psychiatrists. The questionnaire began with the presen-
tation of a typical case of SCD—a 25-year-old man without
any known medical history, who died suddenly while
playing tennis. The subsequent questions concerned the
respondents handling of the case focusing on the forensic
autopsy, addressing the judges’ orders, macroscopical and
microscopical cardiac examination, conduction tissue ex-
amination, immunohistochemistry and electron microscopy,
biochemical markers, and the sampling and storage of
material for genetic and toxicological analyses. Some
questions concerned the legal and ethical aspects of genetic
analyses in postmortem testing, as well as the existence of
any multidisciplinary collaboration.
Respondents
A total of 97 surveys were completed, the majority from
central and southern Europe and the Mediterranean. The
numbers of respondents by countries are listed in Table 1.
Of the respondents, 74.7% male and 25.3% were female.
Of the respondents, 69.1% worked in a university
setting, 6.2% in peripheral hospitals, 4.1% in private
practice, and 18.6% in miscellaneous places (mostly
judicial administration). Of the respondents, 70.1% worked
in forensic pathology, 6.2% in forensic genetics, 4.1% in
forensic toxicology, and the remainder in clinical forensic
medicine. Of the respondents, 58.9% were involved in
teaching forensic medicine.
The professional experience of respondents was the
following: 44.3% had between 1 and 10 years of experi-
ence, 34% between 11 and 20 years, 11.3% between 21 and
30 years, and 4.1% greater than 30 years.
The estimated mean number of autopsies and sudden
cardiac death autopsies performed annually were 180 and
20, respectively.
Autopsy ordering
Of the respondents, 90.8% reported that in the presented
case, the police officer (or investigating magistrate) would
order a forensic autopsy. Of the respondents, 72.2% noted
that the forensic autopsy did not require the consent of the
next of kin, while 18.6% said that it did. Ten percent of the
respondents reported that a postmortem investigation would
not be performed for the presented case.
For the respondents who said that an autopsy would not be
performed for the presented case, or would be performed in
less than 50% of cases, 28.9% noted it was mainly due to the
lack of suspicion of third party intervention, while 11.3%
noted it was due to insufficient resources. Other reasons were
given for 59.8% of respondents, some of which were detailed
in the free-text comments. The differences between countries
are shown in Table 2.
Complementary exams performed in the autopsies
of SCD cases
Of the forensic pathologists, 56.7% perform the cardiac
examination alone or with the help of a pathologist who has
a deeper knowledge of cardiovascular pathology. Thirty four
percent of the respondents fix the whole heart and referee the
case to an expert on cardiovascular pathology. For 9.3% of the
respondents, their practice varies depending on the pathology
found, but that most frequently the forensic pathologist
performs the initial examination and then fixes the entire
heart before sending it to a specialized pathologist. Differ-
ences between countries are shown in Table 2.
Histological examination of the myocardium using
haematoxylin-eosin stain is systematically performed by
71.7% of respondents. This examination is never practiced, or
practiced in less than 50% of cases, by 18.4% of forensic
pathologists. Examination of the conduction tissue is system-
atically performed by 20.6% of respondents, while 62.9% of
respondents never perform it or do so in less than 50% of cases.
Immunohistochemical examination of the myocardium
is systematically performed or performed in more than
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50% of cases by 7.3% of respondents, and never
performed by 57.7% of respondents. Of the respondents,
7.2% did not know if immunohistochemical examination
is performed or not.
Electron microscopy of the myocardium is systematical-
ly performed or performed in more than 50% of cases by
5.1% of respondents, and never performed by 86.6% of
respondents. Of the respondents, 5.5% did not know if
electron microscopy is performed or not.
Measurement of biomarkers (such as troponine, BNP,
NT-proBNP) is practiced systematically or in more than
50% of cases by only 10.3% of respondents, never by
59.8%, and in less than 50% of cases by 23.7%.
Toxicological analyses are practiced systematically by
73.2% of respondents, and never or in less than in 50% of
cases by 13.4% (see Table 3).
No significant statistical differences were observed in the
responses between individuals working in a university
setting and other institutions, namely judicial centers.
EDTA and frozen myocardium sampling
EDTA blood is collected systematically by 49% of respond-
ents, and never collected by 38.1%. The sampling of frozen
myocardium, useful not only for molecular autopsy but also for
the detection of viruses in cases suspicious for myocarditis, is
systematically performed by 15.5% of respondents, and never
or in less than 50% of cases by 79.4% of respondents (see
Table 3).
Postmortem genetic testing
Of the respondents, 40.2% report having the ability to perform
a molecular autopsy, while 59.8% are not able to. Only a
minority of respondents have the possibility to analyze the
three genes currently implicated in cardiac channelopathies
along with some other genes implicated in hypertrophic
cardiomyopathy, arrhythmogenic right ventricular dysplasia/
Table 1 The respondents and their ability to perform genetic postmortem analyses in cases of SCD listed by country (number of respondents who
answered that analysis is possible)
Country Numbers of
respondents/
questionnaires
Possibility to
perform genetic
testing
Analysis
of SCN5A
Analysis
of KCNQ1
Analysis
of KCNH2
Analysis
of RyR2
Analysis of
genes implicated
in HCM
Analysis of
genes implicated
in ARDV/C
Argentina 1/4 1 1 - - - - -
Australia 2/2 2 - 1 1 1 1 1
Austria 1/14 - - - - - - -
Belgium 1/16 - - - - - - -
Canada 2/2 1 - - - - -
Colombia 1/3 - - - - - - -
Croatia 1/3 1 1 1 1 1 1 1
Denmark 2/5 2 1 1 1 1 2 2
France 12/156 4 2 2 2 2 3 2
Germany 10/148 6 5 5 5 4 4 4
Iceland 1/3 - - - - - - -
India 3/3 1 - - - - - -
Italy 4/24 3 1 1 1 1 2
Japan 1/19 1 1 1 1 1 - -
Lebanon 2/2 - - - - - - -
Nigeria 1/1 - - - - - - -
Portugal 4/12 - - - - - - -
Romania 2/3 2 - - - - 1 1
Senegal 1/2 - - - - - - -
Serbia 1/1 1 1 1 1 1 - -
Singapore 1/1 1 1 1 1 1 1 1
Slovakia 1/1 - - - - - - -
Spain 14/20 6 3 2 3 3 5 6
Switzerland 9/119 3 3 3 3 0 2 -
The Nederland 1/2 1 - - - - - -
Turkey 13/13 - - - - - -
United Kingdom 1/4 - - - - - - -
Unites States 2/4 1 - - - - - -
Others countries 0/16
HCM hypertrophic cardiomyopathy, ARDV/C arrhythmogenic right ventricular dysplasia/cardiomyopathy
Int J Legal Med (2011) 125:359–366 361
cardiomyopathy, and polymorphic ventricular tachycardia (see
Table 1). No significant differences were observed between
pathologists working in the university setting and other
institutions.
Legal and ethical aspect of retrospective postmortem
genetic testing
A few questions concerned the legal and ethical aspects of
genetic analyses in the forensic context. One of the
questions asked if the forensic pathologist needs the
approval of the ethics committee and/or the consent of
the next of kin in order to perform a retrospective study. Of
the respondents, 18.6% (two from Germany, two from
Portugal, two from Romania, one from Austria, one from
Croatia, one from Italy, one from Japan, one from Nigeria,
one from Serbia, one from Slovakia, four from Spain, and
one from the USA) may perform genetic analyses in any case
without the consent of the next of kin or the ethics
committee. Of the respondents, 25.6% need the approval of
the local ethics committee and the consent of the next of kin
Table 3 Complimentary exams and sampling of material for molecular autopsy. The question concerning the toxicological exams was: “In cases
of sudden death mentioned above, if the autopsy is negative, how often do you perform complete toxicological analyses (and not only an
immunoassays screening)”
Number of answers
(Percentage)
All respondents Spain Turkey France Germany Switzerland Portugal Italy
97 (100) 14 (100) 13 (100) 10 (100) 10 (100) 9 (100) 4 (100) 4 (100)
Performing of
toxicological
analyses after
a negative
autopsy
Never 5 (5.2) 0 (0) 1 (7.7) 1 (10) 1 (10) 1 (11.1) 0 (0) 0 (0)
In less than 50%
of cases
8 (8.3) 0 (0) 0 (0) 1 (10.0) 4 (40.0) 0 (0) 0 (0) 0 (0)
In more than 50%
of cases
13 (13.4) 2 (14.3) 0 (0) 2 (20.0) 2 (20.0) 1 (11.1) 1 (25.0) 1 (25.0)
In every or almost
every case
71 (73.2) 12 (85.7) 12 (92.3) 6 (60.0) 3 (30.0) 7 (77.8) 3 (75.0) 3 (75.0)
Sampling of
EDTA blood
Never 37 (38.1) 5 (35.7) 4 (30.8) 4 (40.0) 5 (50.0) 1 (11.1) 1 (25.0) 0 (0)
In less than 50%
of cases
7 (7.2) 1 (7.1) 1 (7.7) 0 (0) 2 (20.0) 0 (0) 1 (25.0) 0 (0)
In more than 50%
of cases
5 (5.2) 0 (0) 1 (7.7) 1 (10.0) 0 (0) 0 (0) 0 (0) 0 (0)
In every or almost
every case
48 (49.5) 8 (57.1) 7 (53.9) 5 (50.0) 3 (30.0) 8 (88.9) 2 (50.0) 4 (100)
Sampling of frozen
myocardium
Never 61 (62.9) 12 (85.7) 9 (69.2) 7 (70.0) 2 (20.0) 5 (55.6) 4 (100) 2 (50.0)
In less than 50%
of cases
16 (16.5) 0 (0) 2 (15.4) 0 (0) 6 (60.0) 0 (0) 0 (0) 1 (25.0)
In more than 50%
of cases
4 (4.1) 1 (7.1) 0 (0) 1 (10) 1 (10.0) 0 (0) 0 (0) 0 (0)
In every or almost
every case
15 (15.5) 1 (7.1) 2 (15.4) 2 (20.0) 1 (10.0) 4 (44.4) 0 (0) 1 (25.0)
3 Complimentary exams and sampling of materia for
molecular autopsy. The question concerning he toxicological exams
was: “In c ses of sudden death mentioned above, if the autopsy is
negative, how often do you perform complete to icological a aly
(and not only an immunoassays screening)”
Table 2 Reasons given by respondents for why autopsies are
performed in less than 50% of cases and answers to the question “n
your experience, if a forensic autopsy is performed in a case of a
sudden cardiac death, who would perform the examination of the
heart?” for the total numbers of respondents (97) and for some
countries. For statistical analysis, only metropolitan France was
included (two answers were from overseas regions)
Number of answers
(Percentage)
All respondents Spain Turkey France Germany Switzerland Portugal Italy
97 (100) 14 (100) 13 (100) 10 (100) 10 (100) 9 (100) 4 (100) 4 (100)
Reason of a low
autopsy rate
Insufficient resources 11 (11.3) 2 (14.3) 2 (15.4) 0 (0) 0 (0) 1 (11.1) 0 (0) 0 (0)
No suspicion of a third
party intervention
28 (28.9) 1 (7.1) 3 (23.1) 7 (70.0) 5 (50.0) 3 (33.3) 1 (25.0) 2 (50.0)
Others 58 (59.8) 11 (78.6) 8 (61.5) 4 (30.0) 5 (50.0) 5 (55.6) 2 (50.0) 2 (50.0)
Who perform the
heart examination?
Forensic pathologist 34 (35.1) 1 (7.1) 2 (15.4) 2 (20.0) 9 (90.0) 4 (44.4) 1 (25.0) 0 (0)
Forensic pathologist helped
by a specialist
21 (21.6) 2 (14.3) 3 (23.1) 1 (10.0) 1 (10.0) 4 (44.4) 2 (50.0) 3 (75.0)
The whole heart is fixed
and send to a specialist
33 (34.0) 10 (71.4) 8 (61.5) 4 (40.0) 0 (0) 1 (11.1) 1 (25.0) 0 (0)
Others 9 (9.0) 1 (7.1) 0 (0) 3 (30) 0 (0) 0 (0) 0 (0) 1 (25.0)
l i r t f r t i r
rf r i l t f r t t ti
i , if f i t i f i f
i t , l f t i ti f t
t f r t t t l r f r t ( ) f r
tri . r t ti ti l l i , l tr lit r
i l (t r r fr r r i )
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(six from Switzerland, five from Germany, three from
France, two from Canada, two from Turkey, one from
Iceland, one from Spain, two undeclared). Of the respond-
ents, 26.8% need either the approval of the local ethics
committee or that of the next of kin. Twenty-two point
seven percent do not have the means of performing
retrospective genetic testing.
Juridical authorisation to perform the molecular
autopsy
One question asked if the pathologist needs the permission
of the investigating magistrate or prosecutor in order to
perform genetic testing. Of the respondents, 23.7% reported
that permission was required before performing the retro-
spective postmortem screening. For juridical investigations,
43 out of 88 respondents do not require the permission of
the investigating magistrate in order to perform the
molecular autopsy, whereas the remaining 45 respondents
need the authorisation in order to determine the cause of
death.
Interdisciplinary collaboration
Collaborations between the departments of medical genet-
ics and cardiology exist for 19.6% of respondents, and
more frequently (p value>0.001) in institutions were
genetic testing takes place (i.e., university setting). Of the
respondents, 61.9% not collaborate with other departments,
which rise to 81.0% in institutions where genetic testing is
not performed. Approximately 20% of respondents who
work in institutions that perform genetic testing do not have
any established collaborations.
Contact with families/family doctors
One questioned asked if there was any contact established
with the surviving family members and/or the family
doctor. Such contact is more frequent in places where
molecular autopsies are performed (p value=0.03, Table 4).
Opinions about genetic testing
Of the respondents, 58.8% think that molecular autopsies
should be performed in every case. Of the respondents,
30.9% noted that testing is too expensive. When third party
intervention is not suspected, 22.7% of respondents think
that the molecular autopsy does not have juridical interest,
16.5% of respondents reported that the interpretation of the
genetic results is too complicated, and 6.2% answered that
the “molecular autopsy is too complicated from the legal
and ethical point of view”. Several respondents highlighted
the fact that occasionally the forensic pathologist never
receives the results of the genetic tests. Others noted that
postmortem genetic testing was often performed “illegally”,
without consent of the deceased or their next of kin. Many
respondents suggested that the ethical issues should be
more thoroughly discussed.
Others comments and propositions
A total of 29 general free-text comments were received, some
of which were very detailed. Many comments concerned the
cost of genetic testing, while others referred to the selection of
cases and the difficulties in the interpretation of results.
Respondents who require juridical authorisation commented
on the occasional disinterest of the investigating magistrate
regarding the determination of the cause of death in cases
without suspicion of third party intervention.
Some respondents suggested that such analyses should
only be performed in academic centers that have ethics
committees and where approval of the next of kin can be
obtained, and that these institutions should perform genetic
testing for other pathologies (not just cardiac disease), in
the hopes of preventing death in living family members.
Several respondents noted that the tests should be covered
by public health funds at no additional cost to the forensic
pathologist or family (e.g., Denmark) and that the samples
should be preserved indefinitely so that relevant inves-
tigations can be performed at a later date upon the request
of the forensic pathologist or the family doctor. Several
respondents also proposed the creation of well-publicized
national centers, funded by state money, to which all these
cases should be referred.
Discussion
According to the results of this survey, genetic testing is
practiced in routine forensic investigations of SCD cases by
only a minority of respondents. Approximately 60% of
respondents do not have the means to perform genetic
postmortem testing and 40% do not collect appropriate
samples to perform these investigations, despite working in
a university setting. There was no statistical difference in
the routine practice of complementary exams, including
molecular autopsy, between respondents who work in the
university setting versus other institutions. The main
reasons why genetic tests are so infrequently used are the
elevated costs of such analyses, and the legal restrictions
involved with the sampling and storage of DNA.
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Our survey shows that routine practice varies widely
with respect to the autopsy ordering, the standard inves-
tigations performed, and the collection and storage of
samples. Molecular autopsies are widely used for research
purposes, but in forensic practice often the most basic
investigations are not systematically performed. Some
institutions do not even perform an autopsy in cases of
SCD, although the extent to which this occurs is very
difficult to evaluate. When an autopsy is performed, there is
often no concurrent histological examination of the myo-
cardium and frequently the impossibility, due to lack of
availability or inexperience, to perform more sophisticated
investigations, such as conduction tissue examination,
immunohistochemistry, electron microscopy, and biochem-
ical marker measurement. Encouraging institutions to
perform routine postmortem genetic testing is inutile if
even the basic tests are not done. The results of this survey
are in accordance with a recent online survey of current
autopsy practices performed in the UK, which showed the
discrepancies between the guidelines published by The
Royal College of Pathology and what is realistically
achieved in daily practice. The reasons suggested by the
authors are related to lack of time, financial constraints, and
the introduction of the Human Tissue Act. [16].
The majority of genetic heart diseases that can cause
sudden cardiac death follow an autosomal dominant
inheritance pattern, meaning that the probability of having
additional family members affected is high. Making a
diagnosis is very important as it may help prevent sudden
deaths in living relatives [17–19]. Unfortunately, the link
between the postmortem forensic investigation of a sudden
cardiac death victim and the clinical investigation of
surviving family members is difficult to establish. This
difficulty may result from legal restrictions, such as the
impossibility to obtain the consent of the next of kin, or
from the inability to contact living family members. The
respondents establish contact with the family in less than
30% of cases and with the family doctor in only 16%. Even
institutions that routinely perform genetic testing only
establish contact with the family members in 20.7% of
cases and with the family doctor in 13.3%. This evokes
several important ethical questions: What happens with the
results in such cases? Do family members have access to
the results?
Another problem in the management of sudden cardiac
death cases is the frequent isolation of the forensic
pathologist from other medical fields. This may result from
the historical fact that the forensic pathologist largely works
in response to requests from magistrates or other judicial
authorities. They infrequently contact other specialists,
except in cases where medical responsibility is implicated.
This isolated approach is not beneficial in SCD cases,
especially in regards to genetic testing and the transmission
of results to families. Unfortunately, collaboration between
the departments of medical genetics and cardiology only
exists for 19.6% of respondents. More than 80% of the
respondents who do not perform genetic testing declared
that they do not collaborate with other departments. If more
institutions begin to perform genetic analyses, the collab-
oration between services will hopefully increase.
Currently, the forensic pathologist acts as an expert and
does not have any clear legal obligations toward the family.
Legal and ethical obligations do exist in other, somewhat
similar cases [20]. The prevailing approach of forensic
practitioners must be re-evaluated. Family members of SCD
victims have increasing access to information via the
Internet; and in their search to find an explanation for the
cause of death, they are sure to pose more and more
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Table 4 Contact with family members and/or the family doctor in
cases of SCD. The responses to two questions (in your practice, do
you have contact with family doctors of victims of SCD? In your
practice, do you have contact with families of victims of SCD?) were
compared with the ability to perform the postmortem genetic analyses
in cases of SCD shown in Table 1
Frequency of contact All respondents (%) Respondents performing
genetic testing (%)
Respondents not performing
genetic testing (%)
Contact with families Never 23.7 20.7 22.8
In less than 50%
of cases
32.9 24.1 42.1
In more than 50%
of cases
12.4 13.8 10.8
Always 28.9 41.4 24.6
Contact with family doctors Never 33.0 13.3 41.4
In less than 50%
of cases
34.0 40.0 34.5
In more than 50%
of cases
16.5 16.7 13.8
Always 16.5 30.0 10.3
Table 4 Contact with family members and/or the family doctor in
cases of SCD. The responses to two questions (in your practice, do
you have contact with family doctors of victims of SCD? In your
ti , t t it f ili f i ti f ) r
r it t ilit t rf r t t rt ti l
i f i l
questions. Guidelines should be established regarding
autopsy procedures in cases of SCD, including the
responsibilities to inform living family members. These
issues go beyond forensic medicine and require a broader
discussion among health care providers. The role of the
forensic pathologist in determining the cause of death might
need to be separated from the public health and ethical
issues of addressing the consequences for the family.
The opinion of those experienced with genetic testing is
that the best solution, currently in place in a few countries,
is the creation of national academic centers to which all
cases of SCD can be referred. Such centers should be well
publicized, funded by central state money and would
require the consent of the next of kin, if available.
A limitation of this study is the low response rate of
15%, which can partially be explained by the fact that the
available mailing lists of members of forensic medical
associations were non-selective and did not list their
professional activities. The questionnaire was, therefore,
sent to many individuals who are not implicated in SCD
cases, i.e., forensic toxicologists, psychiatrists, specialists in
clinical legal medicine, etc. The low response rate of
forensic pathologists working in peripheral hospitals or in
private practice may indicate that the non-respondents of
this survey are either not interested in cases of SCD or do
not have the means to appropriately investigate them. The
presented data reflects the practices and opinions of people
who are most likely interested in the topic of SCD. Taking
this into consideration, the percentage of institutions where
a full investigation of SCD occurs is likely lower than that
reported in this study.
It would be very difficult to selectively contact all
individuals who perform SCD autopsies considering the
variations of forensic medical structures and practices in
different countries. In many countries, the molecular
autopsies in cases of SCD are already performed by
professionals not trained in forensic medicine (i.e., cardiol-
ogist or cardiac pathologists) in order to properly inform
living family members. In our opinion, the importance of
the genetic origin of many cardiac diseases, which can
result in SCD, must be emphasized, in the hopes of
establishing multidisciplinary collaborations between foren-
sic pathologists and other experts in the medical field.
Conclusion
This survey shows that many of the problems involved in
the adequate investigation of SCD cases are financial in
origin, and caused by the fact that activities in forensic
medicine are paid by and often dependent on the judicial
authorities. Problems also exist concerning the contact with
the family members and/or the family doctor, as well as the
often-nonexistent collaboration with others clinicians with
special expertise, such as cardiologists and geneticists.
It is too soon to draft final guidelines concerning molecular
autopsies. As an initial step, we propose that each country
should establish a clear legal framework for postmortem
genetic analysis in the forensic context. In our opinion, a
complete autopsy following the existing recommendations
should be performed in all cases of SCD, and a second
opinion should be obtained from an expert in the field of
cardiovascular pathology. In the near future, the criteria for
performing a molecular autopsy should be established in the
by a team of international experts. The appropriate sampling
and storage of material for genetic analyses is essential in the
anticipation of future technical progress. Finally, forensic
pathologists should realize the importance of the genetic
origin of many cardiac diseases resulting in SCD and attempt
to establish multidisciplinary collaborations.
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